Michela Ortoncelli

5PUBLICATIONS
84CO-AUTHORS
Molecular targetsAllergyEpidemiological methodsToxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 05, 2026
Prevalence of Regulatory Safety Risk Factors Among Adolescents and Adults With Atopic Dermatitis Receiving Advanced Systemic Therapies: An International Real-World Study.

|Jul 22, 2026
Treatment Outcomes of Lebrikizumab after Switching from Dupilumab in Moderate-to-Severe Atopic Dermatitis involving the Head and Neck Area.

|Apr 15, 2026
Efficacy and Safety of Abrocitinib for Moderate-to-severe Atopic Dermatitis in Adults: A 52-week Real-world Multicentre StudyIL-AD (Italian Landscape Atopic Dermatitis).

Elena Pezzolo, Rossi Mariateresa, Raul Armando Luyo Saboya

|Oct 10, 2025
Effectiveness, Safety, and Health-Related Quality of Life in Moderate-to-Severe Atopic Dermatitis Treated with Lebrikizumab: A 16-Week Nationwide Retrospective Cohort Study.

Gianluca Avallone, Andrea Bombelli, Luigi Gargiulo

|Mar 31, 2025
Risk Assessment in Atopic Dermatitis: Guidance from a Multidisciplinary Expert Panel.

Alessandra Narcisi, Vito Di Lernia, Maria Esposito

Pageof 1

Frequent Collaborators

5 joint publications

Silvia Mariel Ferrucci

4 joint publications

Alessandra Narcisi

4 joint publications

Maria Esposito

4 joint publications

Maddalena Napolitano